Ven Bio Partners LLC Cin Cor Pharma, Inc. Transaction History

Ven Bio Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$10.75 - $29.84 $15.9 Million - $44.1 Million	-1,478,866 Reduced 79.41%	383,390 $4.71 Million
Q3 2022 Nov 14, 2022	SELL	$19.9 - $38.94 $5.63 Million - $11 Million	-282,779 Reduced 13.18%	1,862,256 $61.1 Million
Q2 2022 Aug 15, 2022	BUY	$13.67 - $25.74 $2.25 Million - $4.23 Million	164,329 Added 8.3%	2,145,035 $40.4 Million
Q1 2022 May 16, 2022	BUY	$14.13 - $28.49 $28 Million - $56.4 Million	1,980,706 New	1,980,706 $34.7 Million

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Ven Bio Partners LLC with notifications on news.